CMS proposes changes to Medicare drug price negotiations
Presented by Philip Morris International {beacon} Health Care Health Care PRESENTED BY The Big Story CMS proposes codifying, strengthening Medicare drug price negotiations The Centers for Medicare and Medicaid Services (CMS) is proposing changes to the Medicare Drug Price Negotiation Program that would codify the requirements of the program and close a potential loophole that drugmakers could exploit. © Jenny...
The Centers for Medicare and Medicaid Services (CMS) is suggesting modifications to the Medicare Drug Price Negotiation Program. The changes aim to formalize the program's rules and eliminate a possible gap that pharmaceutical companies might use. The proposal is part of ongoing efforts to manage prescription drug costs. CMS is seeking public feedback on the suggested updates. The adjustments could impact how drug prices are determined for Medicare beneficiaries. The initiative aligns with broader policy goals to increase transparency and affordability. The proposal is currently under review.
The changes could affect the cost and availability of medications for millions of Medicare recipients.
📌 Kaynak
Bu özet United States kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →